Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2009
11/03/2009CA2404210C Pharmaceutical gel composition
11/03/2009CA2383220C Controlled release pellet formulation
11/03/2009CA2372668C Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts
11/03/2009CA2181548C Zinc finger protein derivatives and methods therefor
10/2009
10/30/2009CA2699190A1 Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment or prevention of toll-like receptor-4-associated disorders
10/29/2009WO2009132149A2 Treatment of conditions related to cecal ligation shock
10/29/2009WO2009132048A2 Treating eosinophilic esophagitis
10/29/2009WO2009131958A2 Compounds, compositions and methods comprising triazine derivatives
10/29/2009WO2009131957A2 Compounds, compositions and methods comprising oxadiazole derivatives
10/29/2009WO2009131696A1 Treatment of hepatitis c virus infections with telaprevir (vx-950) in patients non-responsive to treatment with pegylated interfer0n-alpha-2a/2b and ribavirin
10/29/2009WO2009131537A1 New therapy of treatment of the irritable bowel syndrome.
10/29/2009WO2009131200A1 Therapeutic agent for irritable bowel syndrome
10/29/2009WO2009131171A1 Novel five-membered ring compound
10/29/2009WO2009131170A1 Five-membered ring compound
10/29/2009WO2009131096A1 Compound having npy y5 receptor antagonist activity
10/29/2009WO2009131065A1 Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009WO2009130735A1 Fatty acid derivatives for oral administration endowed with high palatability
10/29/2009WO2009130478A1 Silicia for the inhinition of a protease
10/29/2009WO2009130447A1 Remineralisation of calcified tissue
10/29/2009WO2009094464A3 Dietary compositions and related methods of use
10/29/2009WO2009048934A3 Probiotics for use in relieving symptoms associated with gastrointestinal disorders
10/29/2009WO2009037264A3 Colonic delivery of antimicrobial agents
10/29/2009WO2009009173A3 Klotho-beta for use in treating cancer, liver disorders, gallstones, wasting syndrome and obesity-related diseases
10/29/2009US20090270455 Therapeutic agent for intestinal diseases and visceral pain
10/29/2009US20090270365 such as N-(2,4-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-2-(piperidin-1-ylmethyl)biphenyl-4-carboxamide, having vanilloid receptor 1 antagonistic activity, used as analgesics
10/29/2009US20090270333 Methods of using motilin homologs
10/29/2009US20090270324 Complement depletion using recombinant human c-3 derivatives
10/29/2009US20090269410 Inhibition of Neovascularization by Cerium Oxide Nanoparticles
10/29/2009US20090269349 Antigenic polypeptides
10/29/2009US20090269328 Dry Composition for Oral Ingestion and Gel Composition Prepared Just Before Use for Oral Ingestion
10/29/2009US20090269305 Novel macrocyclic inhibitors of hepatitis c virus replication
10/29/2009US20090269285 Diagnostic And Therapeutic Epitope, And Transgenic Plant
10/29/2009CA2722306A1 Treatment of hepatitis c virus infections with telaprevir (vx-950) in patients non-responsive to treatment with pegylated interferon-alpha-2a/2b and ribavirin
10/29/2009CA2722209A1 Compositions for the treatment and prevention of infections of the oral cavity
10/29/2009CA2722112A1 Treating eosinophilic esophagitis
10/29/2009CA2722075A1 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009CA2722041A1 Novel five-membered ring compound
10/29/2009CA2722007A1 Five-membered ring compound
10/29/2009CA2721801A1 Remineralisation of calcified tissue
10/29/2009CA2721756A1 Fatty acid derivatives for oral administration endowed with high palatability
10/29/2009CA2721576A1 Compound having npy y5 receptor antagonist activity
10/29/2009CA2717210A1 Silicia for the inhinition of a protease
10/28/2009EP2112222A1 Gene encoding guanine nucleotide exchange factor and gene product thereof
10/28/2009EP2112219A1 Novel lactic acid bacteria
10/28/2009EP2112161A2 Peptides that lower blood glucose levels
10/28/2009EP2112140A1 Chinazolin derivatives, medicine containing these compounds, application thereof and method for their production
10/28/2009EP1765343B1 Use of substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines in the treatment of nausea and vomiting
10/28/2009EP1503800B1 Treatment and prevention of tissue damage associated with increased c-reactive protein production
10/28/2009EP1501538B1 Use of alpha-s2 casein precursor-derived peptides
10/28/2009EP1404323B1 Use of methylnaltrexone to treat immune suppression
10/28/2009EP1379504B1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
10/28/2009EP1272168B2 Small organic molecule regulators of cell proliferation
10/28/2009EP1181047B2 Composition comprising alkaline sphingomyelinase of bacterial origin for use as a dietetic preparation, food supplement or pharmaceutical product
10/28/2009EP1150666B1 Gm-csf for the treatment of crohn's disease
10/28/2009CN101568331A Method for reducing or alleviating inflammation in the digestive tract
10/28/2009CN101565671A Health-care medicinal liquor
10/28/2009CN101565452A Immune 7P truncated peptide and application thereof
10/28/2009CN101565444A Circular altin type triterpene in Kleinhovia hospital as well as preparation method and application thereof
10/28/2009CN101564534A Specific yolk antibody preparation for controlling halitosis pathogens and application thereof
10/28/2009CN101564533A Hepatitis E protein-nucleic acid composite vaccine and preparation method thereof
10/28/2009CN101564528A Chinese traditional medicine for curing diarrhea and preparation method thereof
10/28/2009CN101564527A Chinese medicament and western medicament combined formulation for treating cancerous diarrhea and processing method thereof
10/28/2009CN101564525A Analysis method for indigestion eliminating granules
10/28/2009CN101564520A Plastic umbilical plaster for external use, preparation method thereof, plastic infantile diarrhea umbilical plaster and preparation method thereof
10/28/2009CN101564516A Traditional Chinese medicine composition for curing chronic hepatitis
10/28/2009CN101564500A Dendrobium noctilucent preparation and preparation method thereof
10/28/2009CN101564496A Plaster for mainly curing osteoarthropathy and soft tissue injury
10/28/2009CN101564473A Traditional Chinese medicine for curing yellow diarrhea and white diarrhea of porkets
10/28/2009CN101564457A Lizardtail lignan dispersible tablet
10/28/2009CN101564456A Lizardtail lignan drop pill
10/28/2009CN101564453A Medicine for treating chronic nonspecific ulcerative colitis and preparation method thereof
10/28/2009CN101564451A Traditional Chinese medicine for curing chicken white diarrhea
10/28/2009CN101564437A Externally applied medicine for curing chronic appendicitis
10/28/2009CN101564430A Oral solution for treating constipation
10/28/2009CN101564427A Preparation method for medicament treating icteric hepatitis
10/28/2009CN101564419A Medicinal composition for protecting liver
10/28/2009CN101564418A Pharmaceutical composition for treating oral ulcer and Behcet syndrome
10/28/2009CN101564402A Rehabilitation new dispersing tablet and preparation method thereof
10/28/2009CN101564401A Toothache medicament
10/28/2009CN101564388A Composition for Danshensu and danshinolic acid B and use thereof
10/28/2009CN101564169A Medlar nutriment, and preparation and application thereof
10/28/2009CN100554425C Deletion mutant of a set of hepatitis B HBx gene and application thereof
10/28/2009CN100554270C Method for preparing dehydrogenated cavidine, dehydrogenated apocavidine and combination
10/28/2009CN100553671C Chinese medicine for treating fatty liver
10/28/2009CN100553668C Preparation method of yin-nourishing fatigue-eliminating wine with micron oligosaccharide, American ginseng, lily, cactus, official dendrobium stem and royal jelly
10/28/2009CN100553655C Chinese traditional medicine good for heart and brain
10/28/2009CN100553649C A composition for regulating intestinal canal flora and improving hypoxia tolerance as well as its preparation method
10/28/2009CN100553646C Use of probiotic lactic acid bacteria for balancing the skin's immune system
10/28/2009CN100553631C Pharmaceutical uses of 4-fluoro-N-(1,2- hydrindenl-2-yl) benzamide
10/28/2009CN100553627C Externally applied medicine liquid and medicine powder for treating recurrent aphtha
10/28/2009CN100553622C An enteric coated mini-pill of pantoprazole sodium
10/28/2009CN100553618C Medication for treating toothache
10/28/2009CN100553614C Preparation method of quickly disintegrating and dissolving solid medicine composition for oral cavity and its tablet
10/28/2009CN100553489C Production of sweet potato prandial fibre containing sweet-potato resistance starch
10/28/2009CN100553475C Feed additive containing the fruit of Chinese wolfberry
10/27/2009US7608718 4,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
10/27/2009US7608691 Antibodies against IL-16 antagonist peptides
10/27/2009US7608683 Human leukocyte antigen pan DR-binding peptides for use in the treatment of infections, inflammatory, autoimmune and cancer diseases; has heat shock protein that is capable of binding to MHC class II molecules
10/27/2009US7608628 Alkylsulphonamide quinolines
10/27/2009US7608625 Method for treating bruxism and bruxism-related diseases
1 ... 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 ... 1258